Pandey A. HBV Pre-S Mutants and Hepatocellular Carcinoma: New Molecular Pathways, Clinical Implications, and Therapeutic Horizons (2020–2025). JEPMR [Internet]. 2025 Oct. 27 [cited 2025 Dec. 1];1(2):87-126. Available from: https://jepmr.nknpub.com/1/article/view/9